p53 and Mdm2 act synergistically to maintain cardiac homeostasis and mediate cardiomyocyte cell cycle arrest through a network of microRNAs

References

• Bieging KT, Mello SS, Attardi LD. Unravelling mechanisms of p53-mediated tumour suppression. Nat Rev Cancer 2014; 14:359-70; PMID:24739573; https://doi.org/10.1038/nrc3711
   PubMed Web of Science ®Google Scholar
• Daniely Y, Dimitrova DD, Borowiec JA. Stress-Dependent Nucleolin Mobilization Mediated by p53-Nucleolin Complex Formation. Mol. Cell. Biol 22, 6014-22 (2002); PMID:12138209; https://doi.org/10.1128/MCB.22.16.6014-6022.2002
   PubMed Web of Science ®Google Scholar
• Olson MOJ. Sensing cellular stress: another new function for the nucleolus? Sci. STKE 2004; 2004:pe10.
   PubMedGoogle Scholar
• Bouafia A, Corre S, Gilot D, Mouchet N, Prince S, Galibert MD. p53 Requires the Stress Sensor USF1 to Direct Appropriate Cell Fate Decision. PLoS Genet 2014; 10:e1004309; PMID:24831529; https://doi.org/10.1371/journal.pgen.1004309
   PubMed Web of Science ®Google Scholar
• Olovnikov I, Kravchenko J, Chumakov P. Homeostatic functions of the p53 tumor suppressor: regulation of energy metabolism and antioxidant defense. Semin Cancer Biol 2009; 19:32-41; PMID:19101635; https://doi.org/10.1016/j.semcancer.2008.11.005
   PubMed Web of Science ®Google Scholar
• Itahana K, Dimri G, Campisi J. Regulation of cellular senescence by p53. Eur. J. Biochem 2001; 268:2784-91; PMID:11358493; https://doi.org/10.1046/j.1432-1327.2001.02228.x
   PubMedGoogle Scholar
• Qian Y, Chen X. Senescence regulation by the p53 protein family. Methods Mol. Biol 2013; 965:37-61; PMID:23296650
   PubMedGoogle Scholar
• Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M, Koutcher JA, Scher HI, Ludwig T, Gerald W, et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 2005; 436:725-30; PMID:16079851; https://doi.org/10.1038/nature03918
   PubMed Web of Science ®Google Scholar
• Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT, Weinberg RA. Tumor spectrum analysis in p53-mutant mice. Curr Biol 1994; 4:1-7; PMID:7922305; https://doi.org/10.1016/S0960-9822(00)00002-6
   PubMed Web of Science ®Google Scholar
• Malkin D. Li-fraumeni syndrome. Genes Cancer 2011; 2:475-84; PMID:21779515; https://doi.org/10.1177/1947601911413466
   PubMedGoogle Scholar
• Zhao Z, Zuber J, Diaz-Flores E, Lintault L, Kogan SC, Shannon K, Lowe SW. p53 loss promotes acute myeloid leukemia by enabling aberrant self-renewal. Genes Dev 2010; 24:1389-402; PMID:20595231; https://doi.org/10.1101/gad.1940710
   PubMed Web of Science ®Google Scholar
• Hu W, Feng Z, Levine AJ. The Regulation of Multiple p53 Stress Responses is Mediated through MDM2. Genes Cancer 2012; 3:199-208; PMID:23150753; https://doi.org/10.1177/1947601912454734
   PubMedGoogle Scholar
• Shi D, Gu W. Dual Roles of MDM2 in the Regulation of p53: Ubiquitination Dependent and Ubiquitination Independent Mechanisms of MDM2 Repression of p53 Activity. Genes Cancer 2012; 3:240-8; PMID:23150757; https://doi.org/10.1177/1947601912455199
   PubMedGoogle Scholar
• Iwakuma T, Lozano G. MDM2, An Introduction 2003;. 1:993-1000.
   Google Scholar
• Moll UM, Petrenko O. The MDM2-p53 interaction. Mol Cancer Res 2003; 1:1001-8; PMID:14707283
   PubMed Web of Science ®Google Scholar
• de Oca Luna RM, Wagner DS, Lozano G. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 1995; 378:203-6; PMID:7477326; https://doi.org/10.1038/378203a0
   PubMed Web of Science ®Google Scholar
• Jones SN, Roe AE, Donehower LA, Bradley A. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 1995; 378:206-8; PMID:7477327; https://doi.org/10.1038/378206a0
   PubMed Web of Science ®Google Scholar
• Agarwal ML, Agarwal A, Taylor WR, Stark GR. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts (p21/WAF1/Li-Fraumeni cells/tetracycline/mimosine/cyclin-cyclin-dependent kinase). Cell Biol 1995; 92:8493-97.
   Google Scholar
• El-Deiry W, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75:817-25; PMID:8242752; https://doi.org/10.1016/0092-8674(93)90500-P
   PubMed Web of Science ®Google Scholar
• Fischer M, Steiner L, Engeland K. The transcription factor p53: not a repressor, solely an activator. Cell Cycle 2014; 13:3037-58; PMID:25486564; https://doi.org/10.4161/15384101.2014.949083
   PubMed Web of Science ®Google Scholar
• Hünten S, Kaller M, Drepper F, Oeljeklaus S, Bonfert T, Erhard F, Dueck A, Eichner N, Friedel CC, Meister G, et al. p53-Regulated Networks of Protein, mRNA, miRNA, and lncRNA Expression Revealed by Integrated Pulsed Stable Isotope Labeling With Amino Acids in Cell Culture (pSILAC) and Next Generation Sequencing (NGS) Analyses. Mol. Cell. Proteomics 2015; 14:2609-29; PMID:26183718; https://doi.org/10.1074/mcp.M115.050237
   PubMed Web of Science ®Google Scholar
• He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5:522-31; PMID:15211354; https://doi.org/10.1038/nrg1379
   PubMed Web of Science ®Google Scholar
• Ha M, Kim VN. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol 2014; 15:509-24; PMID:25027649; https://doi.org/10.1038/nrm3838
   PubMed Web of Science ®Google Scholar
• Wahid F, Shehzad A, Khan T, Kim YY. MicroRNAs: Synthesis, mechanism, function, and recent clinical trials. Biochim Biophys Acta - Mol Cell Res 2010; 1803:1231-43; https://doi.org/10.1016/j.bbamcr.2010.06.013
   PubMed Web of Science ®Google Scholar
• Hermeking H. MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat Rev Cancer 2012; 12:613-26; PMID:22898542; https://doi.org/10.1038/nrc3318
   PubMed Web of Science ®Google Scholar
• Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, Bentwich Z, Oren M. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 2007; 26:731-43; PMID:17540598; https://doi.org/10.1016/j.molcel.2007.05.017
   PubMed Web of Science ®Google Scholar
• Chang T-C, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ, et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell 2007; 26:745-52; PMID:17540599; https://doi.org/10.1016/j.molcel.2007.05.010
   PubMed Web of Science ®Google Scholar
• Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R, Love RE, Zhai Y, Giordano TJ, Qin ZS, Moore BB, et al. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr. Biol 2007; 17:1298-307; PMID:17656095; https://doi.org/10.1016/j.cub.2007.06.068
   PubMed Web of Science ®Google Scholar
• Hinkel R, Ng JKM, Kupatt C. Targeting microRNAs for cardiovascular therapeutics in coronary artery disease. Curr Opin Cardiol 2014; 29:586-94; PMID:25159281
   PubMed Web of Science ®Google Scholar
• Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW. Y. C. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guideli. Am. Coll. Cardiol. Web Site. Circulation 2006; 113(7):e166-286; available at: http://www.acc.org/clinical/guidelines/failure//index.pdf
   Google Scholar
• Bolli R, Chugh AR, D'Amario D, Loughran JH, Stoddard MF, Ikram S, Beache GM, Wagner SG, Leri A, Hosoda T, et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): Initial results of a randomised phase 1 trial. Lancet 2011; 378:1847-57; PMID:22088800
   PubMed Web of Science ®Google Scholar
• Senyo SE, Lee RT, Kühn B. Cardiac regeneration based on mechanisms of cardiomyocyte proliferation and differentiation. Stem Cell Res 2014; 13:532-41; PMID:25306390
   PubMed Web of Science ®Google Scholar
• Krum H, Abraham WT. Heart failure. Lancet 2009; 373:941-55; PMID:19286093
   PubMed Web of Science ®Google Scholar
• Song H, Conte JV, Foster AH, McLaughlin JS, Wei C. Increased p53 protein expression in human failing myocardium.e. J Hear Lung Transplant 1999; 18:744-9.
   PubMed Web of Science ®Google Scholar
• Ehler E, Moore-Morris T, Lange S. Isolation and Culture of Neonatal Mouse Cardiomyocytes. J Vis Exp 2013; e50154-e50154; https://doi.org/10.3791/50154
   Web of Science ®Google Scholar
• Mak TW, Hauck L, Grothe D, Billia F. p53 regulates the cardiac transcriptome. Proc Natl Acad Sci U S A 2017; 114:2331-36; PMID:28193895
   PubMed Web of Science ®Google Scholar
• van Opbergen CJM, Delmar M, van Veen TAB. Potential new mechanisms of pro-arrhythmia in arrhythmogenic cardiomyopathy: focus on calcium sensitive pathways. Netherlands Hear J 2017; 25(3):157-69; https://doi.org/10.1007/s12471-017-0946-7
   PubMed Web of Science ®Google Scholar
• Shi L, Jackstadt R, Siemens H, Li H, Kirchner T, Hermeking H. p53-induced miR-15a/16-1 and AP4 form a double-negative feedback loop to regulate epithelial-mesenchymal transition and metastasis in colorectal cancer. Cancer Res 2014; 74:532-42; PMID:24285725; https://doi.org/10.1158/0008-5472.CAN-13-2203
   PubMed Web of Science ®Google Scholar
• Koutsoulidou A, Mastroyiannopoulos NP, Furling D, Uney JB, Phylactou LA. Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle. BMC Dev Biol 2011; 11:34; PMID:21645416; https://doi.org/10.1186/1471-213X-11-34
   PubMed Web of Science ®Google Scholar
• Chen W, Frangogiannis NG. Fibroblasts in post-infarction inflammation and cardiac repair. Biochim Biophys Acta 2013; 1833:945-53; https://doi.org/10.1016/j.bbamcr.2012.08.023
   PubMed Web of Science ®Google Scholar
• Krützfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M. Silencing of microRNAs in vivo with ‘antagomirs’. Nature 2005; 438:685-89; PMID:16258535; https://doi.org/10.1038/nature04303
   PubMed Web of Science ®Google Scholar
• Krützfeldt J, Kuwajima S, Braich R, Rajeev KG, Pena J, Tuschl T, Manoharan M, Stoffel M. Specificity, duplex degradation and subcellular localization of antagomirs. Nucleic Acids Res 2007; 35:2885-92; PMID:17439965; https://doi.org/10.1093/nar/gkm024
   PubMed Web of Science ®Google Scholar
• Rhind N, Russell P. Signaling pathways that regulate cell division. Cold Spring Harb. Perspect Biol 2012; 4:a005942-; PMID:23028116; https://doi.org/10.1101/cshperspect.a005942
   PubMed Web of Science ®Google Scholar
• Sah VP, Attardi LD, Mulligan GJ, Williams BO, Bronson RT, Jacks T. A subset of p53-deficient embryos exhibit exencephaly. Nat Genet 1995; 10:175-80; PMID:7663512; https://doi.org/10.1038/ng0695-175
   PubMed Web of Science ®Google Scholar
• Krinka D, Raid R, Pata I, Kärner J, Maimets T. In situ hybridisation of chick embryos with p53-specific probe and their immunostaining with anti-p53 antibodies. Anat. Embryol. (Berl) 2001; 204:207-15; PMID:11681800; https://doi.org/10.1007/s004290100195
   PubMedGoogle Scholar
• Bueno MJ, Malumbres M. MicroRNAs and the cell cycle. Biochim. Biophys. Acta - Mol. Basis Dis 2011; 1812:592-601; https://doi.org/10.1016/j.bbadis.2011.02.002
   PubMed Web of Science ®Google Scholar
• Berthet C, Kaldis P. Cdk2 and Cdk4 cooperatively control the expression of Cdc2. Cell Div 2006; 1:10; PMID:16759374; https://doi.org/10.1186/1747-1028-1-10
   PubMed Web of Science ®Google Scholar
• Malumbres M, Sotillo R, Santamaría D, Galán J, Cerezo A, Ortega S, Dubus P, Barbacid M. Mammalian Cells Cycle without the D-Type Cyclin-Dependent Kinases Cdk4 and Cdk6. Cell 2004; 118:493-504; PMID:15315761; https://doi.org/10.1016/j.cell.2004.08.002
   PubMed Web of Science ®Google Scholar
• Berthet C, Aleem E, Coppola V, Tessarollo L, Kaldis P. Cdk2 Knockout Mice Are Viable. Curr Biol 2003; 13:1775-85; PMID:14561402; https://doi.org/10.1016/j.cub.2003.09.024
   PubMed Web of Science ®Google Scholar
• Aleem E, Kiyokawa H, Kaldis P. Cdc2–cyclin E complexes regulate the G1/S phase transition. Nat. Cell Biol 2005; 7:831-6; PMID:16007079; https://doi.org/10.1038/ncb1284
   PubMed Web of Science ®Google Scholar
• Huang W, Tian SS, Hang PZ, Sun C, Guo J, Du ZM. Combination of microRNA-21 and microRNA-146a Attenuates Cardiac Dysfunction and Apoptosis During Acute Myocardial Infarction in Mice. Mol Ther Acids 2016; 5:e296; https://doi.org/10.1038/mtna.2016.12
   PubMedGoogle Scholar
• Hurford RK, Cobrinik D, Lee M-H, Dyson N. pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev 1997; 11(11):1447-63.
   PubMed Web of Science ®Google Scholar
• Abe S, Nagasaka K, Hirayama Y, Kozuka-Hata H, Oyama M, Aoyagi Y, Obuse C, Hirota T. The initial phase of chromosome condensation requires Cdk1-mediated phosphorylation of the CAP-D3 subunit of condensin II. Genes Dev 2011; 25:863-74; PMID:21498573; https://doi.org/10.1101/gad.2016411
   PubMed Web of Science ®Google Scholar
• Baquero MT, Hanna JA, Neumeister V, Cheng H, Molinaro AM, Harris LN, Rimm DL. Stathmin expression and its relationship to microtubule-associated protein tau and outcome in breast cancer. Cancer 2012; 118:4660-9; PMID:22359235; https://doi.org/10.1002/cncr.27453
   PubMed Web of Science ®Google Scholar
• Pasumarthi KBS, Nakajima H, Nakajima HO, Soonpaa MH, Field LJ. Targeted Expression of Cyclin D2 Results in Cardiomyocyte DNA Synthesis and Infarct Regression in Transgenic Mice. Circ Res 2004; 96:110-118; PMID:15576649; https://doi.org/10.1161/01.RES.0000152326.91223.4F
   PubMed Web of Science ®Google Scholar
• Tane S, Okayama H, Ikenishi A, Amemiya Y, Nakayama KI, Takeuchi T. Two inhibitory systems and CKIs regulate cell cycle exit of mammalian cardiomyocytes after birth. Biochem Biophys Res Commun 2015; 466:147-154; PMID:26363457; https://doi.org/10.1016/j.bbrc.2015.08.102
   PubMed Web of Science ®Google Scholar
• Cheng RK, Asai T, Tang H, Dashoush NH, Kara RJ, Costa KD, Naka Y, Wu EX, Wolgemuth DJ, Chaudhry HW. Cyclin A2 induces cardiac regeneration after myocardial infarction and prevents heart failure. Circ Res. 2007; 100(12):1741-1748; PMID:17495221; https://doi.org/10.1161/CIRCRESAHA.107.153544
   PubMed Web of Science ®Google Scholar
• Tamamori-Adachi M, Hayashida K, Nobori K, Omizu C, Yamada K, Sakamoto N, Kamura T, Fukuda K, Ogawa S, Nakayama KI, et al. Down-regulation of p27Kip1 promotes cell proliferation of rat neonatal cardiomyocytes induced by nuclear expression of cyclin D1 and CDK4. Evidence for impaired Skp2-dependent degradation of p27 in terminal differentiation. J Biol Chem. 2004; 279(48):50429-50436. doi:10.1074/jbc.M403084200; PMID:15371458; https://doi.org/10.1074/jbc.M403084200
   PubMed Web of Science ®Google Scholar
• Muralidhar SA, Sadek HA. Meis1 regulates postnatal cardiomyocyte cell cycle arrest. Etiol Morphog Congenit Hear Dis From Gene Funct Cell Interact to Morphol. 2016; 497(7448):93-101. https://doi.org/10.1007/978-4-431-54628-3_11
   Google Scholar
• Murata-Hori M, Tatsuka M, Wang Y-L. Probing the dynamics and functions of aurora B kinase in living cells during mitosis and cytokinesis. Mol Biol Cell 2002; 13:1099-108; PMID:11950924; https://doi.org/10.1091/mbc.01-09-0467
   PubMed Web of Science ®Google Scholar
• Lin Z, Pu WT. Strategies for cardiac regeneration and repair. Sci Transl Med 2014; 6:239rv1; PMID:24898748; https://doi.org/10.1126/scitranslmed.3006681
   PubMed Web of Science ®Google Scholar
• Lin Z, Zhou P, von Gise A, Gu F, Ma Q, Chen J, Guo H, van Gorp PR, Wang DZ, Pu WT. Pi3kcb links Hippo-YAP and PI3K-AKT signaling pathways to promote cardiomyocyte proliferation and survival. Circ Res 2015; 116:35-45; PMID:25249570; https://doi.org/10.1161/CIRCRESAHA.115.304457
   PubMed Web of Science ®Google Scholar
• von Gise A, Lin Z, Schlegelmilch K, Honor LB, Pan GM, Buck JN, Ma Q, Ishiwata T, Zhou B, Camargo FD, et al. YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy. Proc Natl Acad Sci 2012; 109:2394-99; https://doi.org/10.1073/pnas.1116136109
   PubMed Web of Science ®Google Scholar
• Zhou J. An emerging role for Hippo-YAP signaling in cardiovascular development. J Biomed Res 2014; 28:251-4.
   Google Scholar
• Engel FB, Schebesta M, Duong MT, Lu G, Ren S, Madwed JB, Jiang H, Wang Y, Keating MT. p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev 2005; 19:1175-87; https://doi.org/10.1101/gad.1306705.chaemic
   PubMed Web of Science ®Google Scholar
• Bersell K, Arab S, Haring B, Kühn B. Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell 2009; 138:257-70; PMID:19632177; https://doi.org/10.1016/j.cell.2009.04.060
   PubMed Web of Science ®Google Scholar
• Jabbour A, Hayward CS, Keogh AM, Kotlyar E, McCrohon JA, England JF, Amor R, Liu X, Li XY, Zhou MD, et al. Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses. Eur J Heart Fail 2011; 13:83-92; PMID:20810473; https://doi.org/10.1093/eurjhf/hfq152
   PubMed Web of Science ®Google Scholar
• Eulalio A, Mano M, Dal Ferro M, Zentilin L, Sinagra G, Zacchigna S, Giacca M. Functional screening identifies miRNAs inducing cardiac regeneration. Nature 2012; 492:376-81; PMID:23222520; https://doi.org/10.1038/nature11739
   PubMed Web of Science ®Google Scholar
• Porrello ER, Johnson BA, Aurora AB, Simpson E, Nam YJ, Matkovich SJ, Dorn GW 2nd, van Rooij E, Olson EN. MiR-15 family regulates postnatal mitotic arrest of cardiomyocytes. Circ Res 2011; 109:670-9; PMID:21778430; https://doi.org/10.1161/CIRCRESAHA.111.248880
   PubMed Web of Science ®Google Scholar
• Yang Y, Cheng HW, Qiu Y, Dupee D, Noonan M, Lin YD, Fisch S, Unno K, Sereti KI, Liao R. MicroRNA-34a Plays a Key Role in Cardiac Repair and Regeneration Following Myocardial Infarction. Circ Res 2015; 117(5):450-59; PMID:26082557; https://doi.org/10.1161/CIRCRESAHA.117.305962
   PubMed Web of Science ®Google Scholar
• Chen J, Huang ZP, Seok HY, Ding J, Kataoka M, Zhang Z, Hu X, Wang G, Lin Z, Wang S, et al. Mir-17-92 cluster is required for and sufficient to induce cardiomyocyte proliferation in postnatal and adult hearts. Circ Res 2013; 112(12):1557-1566; PMID:23575307; https://doi.org/10.1161/CIRCRESAHA.112.300658
   PubMed Web of Science ®Google Scholar
• Wahlquist C, Jeong D, Rojas-Muñoz A, Kho C, Lee A, Mitsuyama S, van Mil A, Park WJ, Sluijter JP, Doevendans PA, et al. Inhibition of miR-25 improves cardiac contractility in the failing heart. Nature 2014; 508:531-5; PMID:24670661; https://doi.org/10.1038/nature13073
   PubMed Web of Science ®Google Scholar
• Graham RM, Harvey RP. The Ontogeny of Cardiac Regeneration. Circ Res 2011; 108:1304-05; PMID:21617133; https://doi.org/10.1161/RES.0b013e318222ba1a
   PubMed Web of Science ®Google Scholar